InvestorsHub Logo
Followers 18
Posts 932
Boards Moderated 0
Alias Born 04/26/2016

Re: None

Friday, 05/19/2017 11:06:01 PM

Friday, May 19, 2017 11:06:01 PM

Post# of 17530
Maybe more than just Dry Eye Syndrome...

Voclosporin is a novel calcineurin inhibitor, developed using a pharmacodynamic approach for use in solid organ transplantation and autoimmune disease. The compound is useful for inflammatory ocular surface diseases selected from the group consisting of dry eye syndrome, Sjögren’s syndrome, uveitis, conjunctivitis, keratitis, keratoconjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis, and autoimmune disorders of the ocular surface, including cicatrizing conjunctivitis, blepharitis, and scleritis.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923205/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News